Kessler Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.51M | Sell |
2,923
-18
| -0.6% | -$18.4K | 1.5% | 22 |
|
|
2026
Q1 | $2.71M | Sell |
2,941
-15
| -0.5% | -$15.2K | 1.28% | 26 |
|
|
2025
Q4 | $3.18M | Sell |
2,956
-1,091
| -27% | -$1.04M | 1.34% | 23 |
|
|
2025
Q3 | $3.09M | Buy |
4,047
+266
| +7% | +$198K | 1.33% | 23 |
|
|
2025
Q2 | $2.95M | Sell |
3,781
-3,183
| -46% | -$2.47M | 1.21% | 25 |
|
|
2025
Q1 | $5.75M | Buy |
6,964
+876
| +14% | +$729K | 2.81% | 18 |
|
|
2024
Q4 | $4.7M | Buy |
6,088
+401
| +7% | +$332K | 2.23% | 22 |
|
|
2024
Q3 | $5.04M | Buy |
5,687
+3,211
| +130% | +$2.89M | 2.59% | 20 |
|
|
2024
Q2 | $2.24M | Hold |
2,476
| – | – | 1.21% | 26 |
|
|
2024
Q1 | $1.93M | Buy |
2,476
+1,840
| +289% | +$1.31M | 1.19% | 25 |
|
|
2023
Q4 | $371K | Hold |
636
| – | – | 0.23% | 46 |
|
|
2023
Q3 | $342K | Sell |
636
-33
| -5% | -$17K | 0.29% | 45 |
|
|
2023
Q2 | $314K | Buy |
669
+33
| +5% | +$13.8K | 0.22% | 49 |
|
|
2023
Q1 | $218K | Hold |
636
| – | – | 0.15% | 65 |
|
|
2022
Q4 | $233K | Hold |
636
| – | – | 0.25% | 51 |
|
|
2022
Q3 | $206K | Hold |
636
| – | – | 0.17% | 57 |
|
|
2022
Q2 | $206K | Hold |
636
| – | – | 0.18% | 55 |
|
|
2022
Q1 | $182K | Buy |
+636
| New | +$164K | 0.11% | 77 |
|
|
2021
Q4 | – | Sell |
-400
| Closed | -$92K | – | 182 |
|
|
2021
Q3 | $92K | Hold |
400
| – | – | 0.07% | 91 |
|
|
2021
Q2 | $92K | Hold |
400
| – | – | 0.07% | 68 |
|
|
2021
Q1 | $75K | Hold |
400
| – | – | 0.1% | 48 |
|
|
2020
Q4 | $68K | Hold |
400
| – | – | 0.07% | 60 |
|
|
2020
Q3 | $59K | Hold |
400
| – | – | 0.07% | 63 |
|
|
2020
Q2 | $66K | Sell |
400
-25,394
| -98% | -$3.9M | 0.08% | 56 |
|
|
2020
Q1 | $3.58M | Sell |
25,794
-3,713
| -13% | -$510K | 4.69% | 5 |
|
|
2019
Q4 | $3.88M | Sell |
29,507
-973
| -3% | -$113K | 3.99% | 6 |
|
|
2019
Q3 | $3.41M | Sell |
30,480
-377
| -1% | -$42K | 3.81% | 6 |
|
|
2019
Q2 | $3.42M | Sell |
30,857
-1,894
| -6% | -$223K | 3.59% | 6 |
|
|
2019
Q1 | $4.25M | Sell |
32,751
-1,125
| -3% | -$137K | 4.24% | 4 |
|
|
2018
Q4 | $3.92M | Buy |
33,876
+23,804
| +236% | +$2.66M | 5.07% | 5 |
|
|
2018
Q3 | $1.08M | Sell |
10,072
-1,116
| -10% | -$112K | 1.11% | 26 |
|
|
2018
Q2 | $955K | Sell |
11,188
-430
| -4% | -$35.3K | 1.14% | 31 |
|
|
2018
Q1 | $899K | Sell |
11,618
-1,268
| -10% | -$102K | 1.14% | 38 |
|
|
2017
Q4 | $1.09M | Buy |
12,886
+102
| +0.8% | +$8.68K | 1.36% | 29 |
|
|
2017
Q3 | $1.09M | Buy |
+12,784
| New | +$1.05M | 1.41% | 22 |
|
|
2016
Q1 | – | Sell |
-37,230
| Closed | -$3.14M | – | 100 |
|
|
2015
Q4 | $3.14M | Buy |
37,230
+1,280
| +4% | +$106K | 4.96% | 2 |
|
|
2015
Q3 | $3.01M | Sell |
35,950
-1,719
| -5% | -$145K | 4.96% | 2 |
|
|
2015
Q2 | $3.15M | Buy |
37,669
+349
| +0.9% | +$26.6K | 5.02% | 2 |
|
|
2015
Q1 | $2.71M | Buy |
37,320
+200
| +0.5% | +$14.2K | 4.6% | 3 |
|
|
2014
Q4 | $2.56M | Sell |
37,120
-34
| -0.1% | -$2.29K | 4.19% | 3 |
|
|
2014
Q3 | $2.41M | Sell |
37,154
-174
| -0.5% | -$11K | 4.24% | 3 |
|
|
2014
Q2 | $2.32M | Buy |
37,328
+234
| +0.6% | +$14K | 4.09% | 4 |
|
|
2014
Q1 | $2.18M | Buy |
37,094
+1,978
| +6% | +$110K | 4.62% | 3 |
|
|
2013
Q4 | $1.79M | Buy |
35,116
+1,691
| +5% | +$84.7K | 3.32% | 6 |
|
|
2013
Q3 | $1.68M | Sell |
33,425
-7,596
| -19% | -$398K | 4.6% | 5 |
|
|
2013
Q2 | $2.02M | Buy |
+41,021
| New | +$2.23M | 5.86% | 3 |
|
Other funds holding LLY
SC
ONB
GIM
WAM
Kessler Investment Group's LLY Position: Q2 2026 in Review
Kessler Investment Group reduced its Eli Lilly (LLY) stake by 0.61% in Q2 2026, selling an estimated $18.4K and leaving 2,923 shares worth $3.51M. The position accounts for 1.5% of the portfolio, ranked #22.
Kessler Investment Group first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.75M in Q1 2025. 1,213 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Kessler Investment Group held 2,923 shares of Eli Lilly worth $3.51M as of Q2 2026.
- Kessler Investment Group sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
- Eli Lilly made up 1.5% of Kessler Investment Group's portfolio in Q2 2026, its #22 holding.
- Kessler Investment Group first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- Kessler Investment Group's Eli Lilly position peaked at $5.75M in Q1 2025.
- 1,213 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Kessler Investment Group's 13F filing for Q2 2026, filed 13 Jul 2026.